Brief: Paion Launches Xerava(R) For Treatment Of Complicated Intra-Abdominal Infections In Adults In Netherlands
Sept 1 (Reuters) - PAION AG PA8G.DE :
* PAION LAUNCHES XERAVA(R) (ERAVACYCLINE) FOR THE TREATMENT
OF
COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN THE
NETHERLANDS
* PROVIDING BROAD-SPECTRUM COVERAGE AGAINST BACTERIAL
PATHOGENS
* XERAVA^(R) IS THIRD PRODUCT LAUNCHED BY PAION IN EUROPE
Source text for Eikon: ID:nEQ4d8v2na
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022